A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 14
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : ATF
Long Form : amino-terminal fragment of uPA
No. Year Title Co-occurring Abbreviation
2015 Dual actions of albumin packaging and tumor targeting enhance the antitumor efficacy and reduce the cardiotoxicity of doxorubicin in vivo. DOX, HSA
2009 Pichia pastoris as a host for secretion of toxic saporin chimeras. ---
2008 Inhibition of tumor growth and metastasis by ATF-Fc, an engineered antibody targeting urokinase receptor. ---
2005 Urokinase-induced smooth muscle cell migration requires PI3-K and Akt activation. PI3K, SMC
2002 Human breast adenocarcinoma cell lines promote angiogenesis by providing cells with uPA-PAI-1 and by enhancing their expression. CM
2001 Adenoviral expression of a urokinase receptor-targeted protease inhibitor inhibits neointima formation in murine and human blood vessels. BPTI
1997 Evidence of a non-conventional role for the urokinase tripartite complex (uPAR/uPA/PAI-1) in myogenic cell fusion. ECM, PAI-1, uPA, uPAR
1996 Contrasting effects of plasminogen activators, urokinase receptor, and LDL receptor-related protein on smooth muscle cell migration and invasion. LRP, PA, PAI-1, SMC, tPA, uPA
1996 Systematic mutational analysis of the receptor-binding region of the human urokinase-type plasminogen activator. ---
10  1995 Increase of a urokinase receptor-related low-molecular-weight molecule in colorectal adenocarcinomas. scu-PA, uPA
11  1994 Receptor binding and degradation of urokinase-type plasminogen activator by human mesangial cells. DFP, MC, PAI-1, TCA, uPA
12  1994 Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta. CM, LTGF-beta, M6P, uPA
13  1991 A soluble, ligand binding mutant of the human urokinase plasminogen activator receptor. uPA
14  1989 Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor. PAI-1, uPA